Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Widespread gene transfer to the retina is challenging as it requires vector systems to overcome physical and biochemical barriers to enter and diffuse throughout retinal tissue. We investigated whether exosome-associated adeno-associated virus, (exo-AAV) enabled broad retinal targeting following intravitreal (IVT) injection, as exosomes have been shown to traverse biological barriers and mediate widespread distribution upon systemic injection. We packaged an AAV genome encoding green fluorescent protein (GFP) into conventional AAV2 and exo-AAV2 vectors. Vectors were IVT injected into the eyes of adult mice. GFP expression was noninvasively monitored by fundus imaging and retinal expression was analyzed 4 weeks post-injection by qRT-PCR and histology. Exo-AAV2 outperformed conventional AAV2 in GFP expression based on fundus image analysis and qRT-PCR. Exo-AAV2 demonstrated deeper penetration in the retina, efficiently reaching the inner nuclear and outer plexiform, and to a lesser extent the outer nuclear layer. Cell targets were ganglion cells, bipolar cells, Müller cells, and photoreceptors. Exo-AAV2 serves as a robust gene delivery tool for murine retina, and the simplicity of production and isolation should make it widely applicable to basic research of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exo-AAV had improved ability to cross the inner limiting membrane of the retina after intravitreal injection in mice (146).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [146]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975 · cited 1×
“Since exosomes can cross the blood brain barrier 17,18 , and we have shown exo-AAV to cross an endothelial barrier 16 , we hypothesized that exosomes might also facilitate penetration of AAV vectors across other barriers, such as between the vitreous and the retina.”
Christianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J.-P., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304266110 · Cited by 903 · cited 1×
“Our group and others have shown extracellular vesicles to be heparin sensitive in their ability to enter cells 22–24 .”
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734
A pathogenic picornavirus acquires an envelope by hijacking cellular membranes
Feng, Z., Hensley, L., McKnight, K. L., Hu, F., Madden, V., Ping, L., Jeong, S.-H., Walker, C., Lanford, R. E., & Lemon, S. M. (2013) · Nature · doi:10.1038/nature12029 · Cited by 713
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
Exosomes for targeted siRNA delivery across biological barriers
EL Andaloussi, S., Lakhal, S., Mäger, I., & Wood, M. J. A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.008 · Cited by 539
An essential receptor for adeno-associated virus infection
Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature16465 · Cited by 532 · cited 4×
“In this study, we found that exo-AAV particles are however, dependent on the universal AAV receptor (AAVR), which is located on the cell surface but highly involved in intracellular trafficking 20 .”
InfluentialTherapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions
György, B., Hung, M. E., Breakefield, X. O., & Leonard, J. N. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124630 · Cited by 515 · cited 1×
“Exosomes represent a promising novel drug and gene delivery vehicle 12 .”
Self-citationHigh-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398 · cited 1×
“Other factors, such as post-cellular entry steps (e.g. proteasome-mediated degradation) are thought to be another barrier to efficient retinal transduction 8 .”
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357 · cited 3×
“Efforts towards mitigation of these barriers has been investigated and shown that mild enzymatic digestion of the ILM with Pronase does improve transduction of the multiple cell types in the retina, with the most robust expression with AAV5 serotype 11 .”
InfluentialImmature dendritic cell-derived exosomes can mediate HIV-1 trans infection
Wiley, R. D., & Gummuluru, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507995103 · Cited by 311 · cited 1×
“Several DNA and RNA viruses have been shown to associate with exosomes 35–38 , possibly through an evolutionally conserved mechanism.”
Microvesicle-associated AAV Vector as a Novel Gene Delivery System
Maguire, C. A., Balaj, L., Sivaraman, S., Crommentuijn, M. H., Ericsson, M., Mincheva-Nilsson, L., Baranov, V., Gianni, D., Tannous, B. A., Sena-Esteves, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.303 · Cited by 283 · cited 2×
“We have recently shown that the uptake of 293T cell-derived EVs into recipient cells can be blocked with heparin 14,23 .”
Self-citationNovel properties of tyrosine-mutant AAV2 vectors in the mouse retina
Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.-T., Pang, J.-J., Min, S.-H., Chiodo, V., Neeley, A. W., Govindasamy, L., Bennett, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.234 · Cited by 267 · cited 2×
“Delivering lower amounts of these vectors (1 × 10 9 vg/eye) only led to RGC and Muller cell transduction with some scattered cells in the inner retina 29 .”
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction
Yang, Y., Han, Q., Hou, Z., Zhang, C., Tian, Z., & Zhang, J. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.24 · Cited by 225
Heparin blocks transfer of extracellular vesicles between donor and recipient cells
Atai, N. A., Balaj, L., van Veen, H., Breakefield, X. O., Jarzyna, P. A., Van Noorden, C. J. F., Skog, J., & Maguire, C. A. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1235-y · Cited by 203 · cited 1×
“We have recently shown that the uptake of 293T cell-derived EVs into recipient cells can be blocked with heparin 14,23 .”
Self-citationSpiteri Cornish, K., Lois, N., Scott, N. W., Burr, J., Cook, J., Boachie, C., Tadayoni, R., la Cour, M., Christensen, U., & Kwok, A. K. H. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.020 · Cited by 198
RNA Binding Protein with Multiple Splicing: A New Marker for Retinal Ganglion Cells
Kwong, J. M. K., Caprioli, J., & Piri, N. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4098 · Cited by 191
Heparin affinity purification of extracellular vesicles
Balaj, L., Atai, N. A., Chen, W., Mu, D., Tannous, B. A., Breakefield, X. O., Skog, J., & Maguire, C. A. (2015) · Scientific Reports · doi:10.1038/srep10266 · Cited by 189 · cited 1×
“Our group and others have shown extracellular vesicles to be heparin sensitive in their ability to enter cells 22–24 .”
Self-citationThe rod bipolar cell of the mammalian retina
Wässle, H., Yamashita, M., Greferath, U., Grünert, U., & Müller, F. (1991) · Visual Neuroscience · doi:10.1017/s095252380001097x · Cited by 170 · cited 2×
“Retinal ganglion cells were stained with antibodies against RNA-binding protein with multiple splicing (RBMPS, 1:100, PhosphoSolutions) 43 , bipolar cells were stained with protein kinase C α antibody (PKC α , Santa Cruz Biotechnology) 44 and calcium binding protein 5 antibody (CaBP5, 1:10 courtesy of Prof. Françoise…”
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Kay, C. N., Ryals, R. C., Aslanidi, G. V., Min, S. H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D., Ayala, A. E., Van Vliet, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062097 · Cited by 168
Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV
Dudus, L., Anand, V., Acland, G. M., Chen, S.-J., Wilson, J. M., Fisher, K. J., Maguire, A. M., & Bennett, J. (1999) · Vision Research · doi:10.1016/s0042-6989(98)00308-3 · Cited by 160 · cited 1×
“It has been reported that vector injected IVT or subretinally in mice and dogs can transduce regions of brain 39 , thus it will be important to assess whether exo-AAV2 displays the same properties.”
György, B., Fitzpatrick, Z., Crommentuijn, M. H. W., Mu, D., & Maguire, C. A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.032 · Cited by 153 · cited 2×
“Recently we have shown that AAV associates with exosomes 14 and that exosome-associated AAV (exo-AAV) vectors represent a novel gene delivery vector with several advantageous properties 15,16 .”
Self-citationJacobson, S. G., Boye, S. L., Aleman, T. S., Conlon, T. J., Zeiss, C. J., Roman, A. J., Cideciyan, A. V., Schwartz, S. B., Komaromy, A. M., Doobrajh, M., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.845 · Cited by 147
Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina
Ramachandran, P. S., Lee, V., Wei, Z., Song, J. Y., Casal, G., Cronin, T., Willett, K., Huckfeldt, R., Morgan, J. I. W., Aleman, T. S., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.111 · Cited by 147 · cited 1×
“This capsid clone enhanced transduction of photoreceptors and RPE following IVT injection 27,28 .”
Exosome-associated AAV vector as a robust and convenient neuroscience tool
Hudry, E., Martin, C., Gandhi, S., György, B., Scheffer, D. I., Mu, D., Merkel, S. F., Mingozzi, F., Fitzpatrick, Z., Dimant, H., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.11 · Cited by 146
Self-citationNovel adeno-associated viral vectors for retinal gene therapy.
Vandenberghe, L. H., & Auricchio, A. (2012) · Gene Therapy · doi:10.1038/gt.2011.151 · Cited by 131
Self-citationMowat, F. M., Gornik, K. R., Dinculescu, A., Boye, S. L., Hauswirth, W. W., Petersen-Jones, S. M., & Bartoe, J. T. (2014) · Gene Therapy · doi:10.1038/gt.2013.64 · Cited by 108
Li, R., Xiaohua, T., Li, Y., Zhang, H., Ma, R., Ji, T., Dong, W., Tong, T., Liu, Y., Chen, D., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.025 · Cited by 105 · cited 1×
“Several DNA and RNA viruses have been shown to associate with exosomes 35–38 , possibly through an evolutionally conserved mechanism.”
Boye, S. L., Bennett, A., Scalabrino, M. L., McCullough, K. T., Van Vliet, K., Choudhury, S., Ruan, Q., Peterson, J., Agbandje-McKenna, M., & Boye, S. E. (2016) · Journal of Virology · doi:10.1128/jvi.00200-16 · Cited by 79 · cited 1×
“Heparin-sensitive binding is implicated in the ability of AAV2 to transduce the retina via IVT injection 21,42 .”
Woodard, K. T., Liang, K. J., Bennett, W. C., & Samulski, R. J. (2016) · Journal of Virology · doi:10.1128/jvi.01568-16 · Cited by 59
Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2.
Cehajic‐Kapetanovic, J., Goff, M. L., Allen, A. E., Lucas, R. J., & Bishop, P. N. (2011) · PubMed Central · Cited by 57
AAV‐mediated gene delivery in Dp71‐null mouse model with compromised barriers
Vacca, O., Darche, M., Schaffer, D. V., Flannery, J. G., Sahel, J., Rendon, A., & Dalkara, D. (2014) · Glia · doi:10.1002/glia.22617 · Cited by 48
Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs
Boyd, R. F., Sledge, D. G., Boye, S. L., Boye, S. E., Hauswirth, W. W., Komáromy, A. M., Petersen‐Jones, S. M., & Bartoe, J. T. (2015) · Gene Therapy · doi:10.1038/gt.2015.96 · Cited by 44 · cited 1×
“Tyrosine mutant AAV capsids (single, triple or quadruple Y-F) were also shown to result in better retinal transduction after intravitreal injection, likely due to decreased proteosomal degradation of the capsid 29–33 .”
Tshilenge, K.-T., Ameline, B., Weber, M., Mendes-Madeira, A., Nedellec, S., Biget, M., Provost, N., Libeau, L., Blouin, V., Deschamps, J.-Y., et al. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.034 · Cited by 34
Da Costa, R., Röger, C., Segelken, J., Barben, M., Grimm, C., & Neidhardt, J. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-19701 · Cited by 32 · cited 1×
“A recent report described the effect of vitreous aspiration of the mouse eye on AAV8 transduction of retina, showing the feasibility in smaller animal models 41 .”
Silva, S. R. D., Issa, P. C., Singh, M. S., Lipinski, D. M., Barnea-Cramer, A. O., Walker, N. J., Barnard, A. R., Hankins, M. W., & MacLaren, R. E. (2016) · Gene Therapy · doi:10.1038/gt.2016.54 · Cited by 30
Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injection
Giove, T. J., Sena-Esteves, M., & Eldred, W. D. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.08.011 · Cited by 27 · cited 1×
“Alternative serotypes such as AAVrh.8 and AAVrh.10 has also shown promise for retinal transduction by the IVT route 34 .”
Park, S. W., Kim, J. H., Park, W. J., & Kim, J. H. (2015) · Journal of Visualized Experiments · doi:10.3791/53030 · Cited by 25
Erratum: Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs
Boyd, R. F., Sledge, D. G., Boye, S. L., Boye, S. L., Hauswirth, W. W., Komáromy, A. M., Petersen‐Jones, S. M., & Bartoe, J. T. (2016) · Gene Therapy · doi:10.1038/gt.2016.10 · Cited by 12
Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Vacca, O., Mathari, B. E., Darche, M., Sahel, J., Rendón, Á., & Dalkara, D. (2015) · Journal of Visualized Experiments · doi:10.3791/52451 · Cited by 9
Cited by
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,285
Extracellular vesicles: novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos, D., Albuquerque, P. R., Carmona, V., Perfeito, R., Nobre, R. J., & Pereira de Almeida, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.001 · Cited by 418
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
Self-citationAAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
“169 An intratumoral administration of AAV6 vexosomes carrying a suicide gene in a murine xenograft model revealed a 2.3-fold increase in hepatocellular carcinoma regression compared with untreated animals.”
BackgroundInfluentialVarious AAV Serotypes and Their Applications in Gene Therapy: An Overview
Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 313
Metadata
- Authors
- Wassmer, S. J., Carvalho, L. S., György, B., Vandenberghe, L. H., & Maguire, C. A.
- Affiliations
- Massachusetts Eye and Ear Infirmary (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- Corresponding author
- György, Bence
- Vandenberghe, Luk H.
- Maguire, Casey A.
- Venue
- Scientific Reports
- Published
- 2017-03-31
- Volume
- 7
- Issue
- 1
- Pages
- 45329-45329
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5374486
- OpenAlex
- W2601308787
- Cited by
- 164
- References
- 46
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 17 · 2023: 22 · 2022: 13 · 2021: 23 · 2020: 26 · 2019: 11 · 2018: 8 · 2017: 8
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
- Funders
- Cure Alzheimer's Fund
- Grousbeck Family Foundation
- National Institutes of Health
- National Eye Institute (DP1EY023177)
- National Institute of Neurological Disorders and Stroke (P30NS045776)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus type 2, retinal gene delivery, intravitreal injection, exosomes, GFP expression, retinal cell types, Müller cells, photoreceptors
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Male, Retina, Gene Transfer Techniques, Green Fluorescent Proteins, Mice, Exosomes, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.